BTC$64,972.29▼ 0.19%ETH$1,830.77▲ 0.13%USDT$0.9993▼ 0.00%BNB$594.11▲ 0.02%USDC$1.00▼ 0.00%XRP$0.9659▲ 0.27%SOL$72.79▲ 0.72%TRX$0.3049▲ 0.27%FIGR_HELOC$1.04▼ 1.70%HYPE$70.21▲ 5.58%ZEC$921.92▲ 2.54%DOGE$0.0593▲ 0.34%XMR$118.70▼ 0.07%LEO$9.28▲ 0.78%USDS$1.00▲ 0.10%WBT$62.80▼ 0.33%LINK$9.20▼ 0.24%ADA$0.1544▲ 0.07%XLM$0.1393▼ 0.54%USDE$1.00▼ 0.02%RAIN$0.006612▲ 91.39%DAI$1.00▲ 0.00%NEAR$3.26▲ 2.09%BCH$209.30▲ 0.18%LTC$44.94▲ 0.04%CC$0.0825▼ 1.68%AVAX$7.17▼ 0.75%UNI$5.26▲ 1.05%XAUT$3,855.45▼ 0.07%SUI$0.7274▼ 0.30%USD1$0.9993▼ 0.02%GRAM$1.04▼ 2.18%RLUSD$1.00▼ 0.01%USDG$1.0000▼ 0.00%HBAR$0.0575▼ 2.61%PYUSD$0.9999▲ 0.05%USDY$1.15▼ 0.02%CRO$0.0440▲ 2.55%SHIB$0.000004▼ 0.81%TAO$193.50▲ 0.56%BTC$64,972.29▼ 0.19%ETH$1,830.77▲ 0.13%USDT$0.9993▼ 0.00%BNB$594.11▲ 0.02%USDC$1.00▼ 0.00%XRP$0.9659▲ 0.27%SOL$72.79▲ 0.72%TRX$0.3049▲ 0.27%FIGR_HELOC$1.04▼ 1.70%HYPE$70.21▲ 5.58%ZEC$921.92▲ 2.54%DOGE$0.0593▲ 0.34%XMR$118.70▼ 0.07%LEO$9.28▲ 0.78%USDS$1.00▲ 0.10%WBT$62.80▼ 0.33%LINK$9.20▼ 0.24%ADA$0.1544▲ 0.07%XLM$0.1393▼ 0.54%USDE$1.00▼ 0.02%RAIN$0.006612▲ 91.39%DAI$1.00▲ 0.00%NEAR$3.26▲ 2.09%BCH$209.30▲ 0.18%LTC$44.94▲ 0.04%CC$0.0825▼ 1.68%AVAX$7.17▼ 0.75%UNI$5.26▲ 1.05%XAUT$3,855.45▼ 0.07%SUI$0.7274▼ 0.30%USD1$0.9993▼ 0.02%GRAM$1.04▼ 2.18%RLUSD$1.00▼ 0.01%USDG$1.0000▼ 0.00%HBAR$0.0575▼ 2.61%PYUSD$0.9999▲ 0.05%USDY$1.15▼ 0.02%CRO$0.0440▲ 2.55%SHIB$0.000004▼ 0.81%TAO$193.50▲ 0.56%

Cure Cancer vs Achi

Cure Cancer (CURECANCER) and Achi (ACH) compared side by side. Their daily returns move loosely together (correlation 0.53 across 21 shared trading days). Both have run at a similar volatility, around 73% annualised.

Correlation
0.53
Cure CancerCURECANCER

$1.738e-6

24h
—
Market cap
—
Volume 24h
$2
Volatility (ann.)
73%
AchiACH

$0.003780

24h
-39.38%
Market cap
—
Volume 24h
$661,006
Volatility (ann.)
73%

Performance

CURECANCERACH

  1. 7 days-21.07%-11.97%ACH
  2. 30 days—-29.78%—
  3. 90 days—-10.07%—
  4. 1 year—-64.42%—

Correlation

0.53over 21 shared trading days

−1 opposite0 unrelated+1 in step
7d: insufficient data30d: insufficient data90d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

MetricCURECANCERACH
Max drawdown (400d)-37.2%-73.8%
Risk-adjusted return (90d)-0.51-0.14
Best 30 days (past year)—+62.8%
Worst 30 days (past year)—-41.8%

Relative strength over 90 days: ACH outperformed CURECANCER by 13.1% — measured on the CURECANCER/ACH ratio, so it holds regardless of market direction.